Your browser doesn't support javascript.
loading
Validation of the GATMO score in predicting non-relapse mortality following hematopoietic cell transplant in multiple myeloma patients.
Awada, Hussein; Hajj Ali, Adel; Zeineddine, Mohammad; Rashid, Mohammad; Anwer, Faiz; Hamilton, Betty; Sauter, Craig; Williams, Louis; Khouri, Jack.
Afiliación
  • Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Hajj Ali A; Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Zeineddine M; Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA.
  • Rashid M; Department of Hematology and Oncology, University of Toledo, Toledo, Ohio, USA.
  • Anwer F; Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Hamilton B; Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Sauter C; Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Williams L; Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Khouri J; Multiple Myeloma Program, Blood and Marrow Transplant program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Eur J Haematol ; 112(2): 314-316, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37804053
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos